Konstantinos Syrigos to Ipilimumab
This is a "connection" page, showing publications Konstantinos Syrigos has written about Ipilimumab.
Connection Strength
0.192
-
Nivolumab plus Ipilimumab in Advanced Non-Small-Cell Lung Cancer. N Engl J Med. 2019 11 21; 381(21):2020-2031.
Score: 0.192
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.